Physician profile
Kyle Nuland
NPI 1548654783
$16,595.45
in general payments reported to CMS, 2019-2025
9 companies · $326 in 2025
The $326 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $6,025 · 2021: $8,530 · 2022: $446 · 2023: $530 · 2024: $737 · 2025: $326.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,494 · Education: $99.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,493.87 |
| Education | $99.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $12,943.41 | 2020-2023 | Ri Hip Navigation, Polarstem, Or3o Dual Mobility |
| Zimmer Biomet Holdings, INC. | $1,902.16 | 2020-2025 | Persona, Avenir |
| Depuy Synthes Sales INC. | $790.21 | 2020-2025 | Attune |
| Stryker Corporation | $452.47 | 2020-2024 | Mako, Insignia |
| Linkbio Corp | $285.51 | 2021 | |
| Medical Device Business Services, INC. | $145.91 | 2021-2025 | Velys |
| Kerecis Limited | $38.28 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Orthalign INC | $26.21 | 2024 | Orthalign Plus |
| Heraeus Medical, LLC. | $11.29 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Nuland listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.